GlassScriptPhysician profile
Cindy H Tran
NPI 1669495164
$1,349.60
in general payments reported to CMS, 2019-2025
11 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $66.46 · 2021: $142 · 2022: $89.14 · 2023: $163 · 2024: $296 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $417.41 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $272.54 | 2019-2025 | Hydrus Microstent, Dailies Total1 |
| Emd Serono, INC. | $128.34 | 2023 | Mavenclad |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.29 | 2019 | |
| Coopervision INC. | $112.83 | 2019-2022 | |
| Glaukos Corporation | $73.55 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $70.83 | 2022-2025 | Infuse |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Genentech USA, INC. | $59.07 | 2019 | |
| Sight Sciences, INC. | $22.15 | 2022 | |
| Abb Con-Cise Optical Group LLC | $7.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.